Ethical Considerations for Unblinding and Vaccinating COVID-19 Vaccine Trial Placebo Group Participants

Detalles Bibliográficos
Autores principales: Stoehr, Jenna Rose, Hamidian Jahromi, Alireza, Thomason, Clayton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264198/
https://www.ncbi.nlm.nih.gov/pubmed/34249853
http://dx.doi.org/10.3389/fpubh.2021.702960
_version_ 1783719499584765952
author Stoehr, Jenna Rose
Hamidian Jahromi, Alireza
Thomason, Clayton
author_facet Stoehr, Jenna Rose
Hamidian Jahromi, Alireza
Thomason, Clayton
author_sort Stoehr, Jenna Rose
collection PubMed
description
format Online
Article
Text
id pubmed-8264198
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82641982021-07-09 Ethical Considerations for Unblinding and Vaccinating COVID-19 Vaccine Trial Placebo Group Participants Stoehr, Jenna Rose Hamidian Jahromi, Alireza Thomason, Clayton Front Public Health Public Health Frontiers Media S.A. 2021-06-24 /pmc/articles/PMC8264198/ /pubmed/34249853 http://dx.doi.org/10.3389/fpubh.2021.702960 Text en Copyright © 2021 Stoehr, Hamidian Jahromi and Thomason. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Stoehr, Jenna Rose
Hamidian Jahromi, Alireza
Thomason, Clayton
Ethical Considerations for Unblinding and Vaccinating COVID-19 Vaccine Trial Placebo Group Participants
title Ethical Considerations for Unblinding and Vaccinating COVID-19 Vaccine Trial Placebo Group Participants
title_full Ethical Considerations for Unblinding and Vaccinating COVID-19 Vaccine Trial Placebo Group Participants
title_fullStr Ethical Considerations for Unblinding and Vaccinating COVID-19 Vaccine Trial Placebo Group Participants
title_full_unstemmed Ethical Considerations for Unblinding and Vaccinating COVID-19 Vaccine Trial Placebo Group Participants
title_short Ethical Considerations for Unblinding and Vaccinating COVID-19 Vaccine Trial Placebo Group Participants
title_sort ethical considerations for unblinding and vaccinating covid-19 vaccine trial placebo group participants
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264198/
https://www.ncbi.nlm.nih.gov/pubmed/34249853
http://dx.doi.org/10.3389/fpubh.2021.702960
work_keys_str_mv AT stoehrjennarose ethicalconsiderationsforunblindingandvaccinatingcovid19vaccinetrialplacebogroupparticipants
AT hamidianjahromialireza ethicalconsiderationsforunblindingandvaccinatingcovid19vaccinetrialplacebogroupparticipants
AT thomasonclayton ethicalconsiderationsforunblindingandvaccinatingcovid19vaccinetrialplacebogroupparticipants

Ejemplares similares